amyloidosis

September 29, 2022

New Clinician Spotlight: Muhamed Baljević

Specializing in myeloma, amyloidosis and other plasma cell disorders, hematologist and medical oncologist Muhamed Baljević, MD, recently joined Vanderbilt University Medical Center.

By VUMC News and Communications
April 11, 2022

Peptides promote AFib arrhythmia

Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.

By Leigh MacMillan
Charlotte Haffner, a former VUMC patient treated for primary AL amyloidosis, with Franklin Mayor Ken Moore, left, and Muhamed Baljevic, MD.
April 7, 2022

Patient’s amyloidosis awareness efforts recognized

Charlotte Haffner, who was Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat primary AL amyloidosis, was recently recognized by Williamson County Mayor Rogers Anderson and Franklin Mayor Ken Moore.

By Matt Batcheldor
April 5, 2018

Patient’s efforts help shine light on plasma cell disorder

Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease.

By Jessica Pasley